With more than 20 steps from the initial decision to prescribe to the patient finally taking the medication, the opportunity for errors in repeat prescribing is great. A Medical Protection risk assessment will assist practices to identify potential risks related to the repeat prescribing system and provide recommendations in how to mitigate the risks identified.
The repeat prescribing risk assessment involves a two or three hour practice visit by one of Medical Protection ’s expert facilitators. During the visit the facilitator will:
- Review the practice’s current approach to repeat prescribing
- Undertake semi-structured interviews with key practice staff
- Identify areas of risk within the practice’s repeat prescribing system
Following the risk assessment the practice will be provided with a brief report of the findings including recommendations to mitigate the risks identified
Repeat prescribing is a complex journey that accounts for 75% of prescriptions issued in general practice.
With more than 20 steps from the initial decision to prescribe to the patient finally taking the medication, the opportunity for error is great. Therefore, it is no wonder that errors in repeat prescribing frequently occur.
Although it is the clinician who ultimately signs the prescription and is legally responsible for it, patients, staff and pharmacists all have an important role to play in minimising the risks involved in the process.
This three-hour workshop will help the practice team to understand the potential for error in your own practice’s repeat prescribing process. Practice teams will identify areas for improvement and discuss solutions to mitigate risk.